| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 2, 2009
From the Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital, Boston (C.N.-C.); Broad Institute of Harvard and MIT, Cambridge, Mass (C.N.-C.); Center for Arrhythmia Prevention (C.M.A.), Division of Preventive Medicine (N.R.C., M.V., P.M.R., C.M.A), Channing Laboratory (E.B.R.), and Cardiovascular Division (C.M.A., P.M.R.), Department of Medicine, Brigham and Women's Hospital (C.M.A.), Harvard Medical School, Boston, Mass; and Departments of Nutrition (E.B.R.) and Epidemiology (N.R.C., E.B.R.), Harvard School of Public Health, Boston Mass. * To whom correspondence should be addressed. E-mail: calbert{at}partners.org.
Background—Although a heritable basis for sudden cardiac death (SCD) is suggested by the impact of family history on SCD risk, common genetic determinants have been difficult to identify. We hypothesized that a common variant at chromosome 9p21 related to myocardial infarction would influence SCD risk. Methods and Results—This was a prospective, nested, case-control analysis among individuals of European ancestry enrolled in 6 prospective cohort studies. Study subjects were followed up for development of SCD, and genotypes for rs10757274 were determined for 492 sudden and/or arrhythmic deaths and 1460 controls matched for age, sex, cohort, history of cardiovascular disease, and follow-up time. Conditional logistic regression with fixed-effects meta-analysis assuming an additive model was used to test for associations. When individual study results were combined in the meta-analysis, each increasing copy of the G allele at rs10757274 conferred a significantly elevated age-adjusted odds ratio for SCD of 1.21 (95% confidence interval, 1.04 to 1.40; P=0.01). Controlling for cardiovascular and lifestyle risk factors strengthened these relationships (odds ratio, 1.29 per G-allele copy; 95% confidence interval, 1.09 to 1.53; P=0.003). These results were not materially altered in sensitivity analyses limited to definite SCD, in models that further controlled for the development of interim cardiovascular disease, or when the highly correlated variant rs2383207 was tested. Conclusions—The major allele of a single-nucleotide polymorphism previously associated with increased risk of coronary artery disease events is associated with increased risk of SCD in individuals of European ancestry. Study of the mechanism underlying this association may improve our understanding of lethal cardiovascular disease.
Accepted on September 16, 2009
A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac Death
Christopher Newton-Cheh MD, MPH,
Related Article:
Circulation 2009 120: 2027-2028.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |